MENU
+Compare
ARGX
Stock ticker: NASDAQ
AS OF
Sep 30 closing price
Price
$737.56
Change
+$18.52 (+2.58%)
Capitalization
43.78B

ARGX argenx SE Forecast, Technical & Fundamental Analysis

Argenx is a Dutch biopharmaceutical company focused on developing antibody-based therapies for rare autoimmune diseases... Show more

ARGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ARGX with price predictions
Sep 29, 2025

ARGX sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for ARGX moved above the 200-day moving average on August 29, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ARGX advanced for three days, in of 298 cases, the price rose further within the following month. The odds of a continued upward trend are .

ARGX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 242 cases where ARGX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for ARGX moved out of overbought territory on September 16, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 29 similar instances where the indicator moved out of overbought territory. In of the 29 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on September 18, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ARGX as a result. In of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ARGX turned negative on September 16, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ARGX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ARGX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.407) is normal, around the industry mean (19.929). P/E Ratio (37.551) is within average values for comparable stocks, (54.169). Projected Growth (PEG Ratio) (1.274) is also within normal values, averaging (2.181). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (16.502) is also within normal values, averaging (352.599).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
ARGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ARGX is expected to report earnings to fall 30.22% to $4.41 per share on October 30

argenx SE ARGX Stock Earnings Reports
Q3'25
Est.
$4.41
Q2'25
Beat
by $3.26
Q1'25
Beat
by $0.34
Q4'24
Beat
by $10.57
Q3'24
Beat
by $1.24
The last earnings report on July 31 showed earnings per share of $6.32, beating the estimate of $3.06. With 343.81K shares outstanding, the current market capitalization sits at 43.78B.
A.I. Advisor
published General Information

General Information

a manufacturer of antibody-based medicines

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
Laarderhoogtweg 25
Phone
+31 107038441
Employees
1148
Web
https://www.argenx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BEGS38.742.18
+5.96%
Rareview 2X Bull Cryptoccy & Prc Mtl ETF
FNGG242.880.77
+0.32%
Direxion Daily NYSE FANG+ Bull 2X Shares
BME36.320.10
+0.28%
Blackrock Health Sciences Trust
EUFN34.160.02
+0.06%
iShares MSCI Europe Financials ETF
FMNY26.46-0.03
-0.11%
First Trust New York High Inc Mncpl ETF

ARGX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ARGX has been loosely correlated with ARGNF. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if ARGX jumps, then ARGNF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARGX
1D Price
Change %
ARGX100%
+1.04%
ARGNF - ARGX
55%
Loosely correlated
N/A
ALNY - ARGX
41%
Loosely correlated
+0.24%
AXON - ARGX
40%
Loosely correlated
+1.01%
APLS - ARGX
38%
Loosely correlated
+1.25%
ARRY - ARGX
36%
Loosely correlated
-2.30%
More